| Abbott and Domantis Collaborate on Antibody Therapeutics |
Abstract
pdf
|
|
Business Review Editor |
|
| Arena and Merck Collaborate on GPCRs |
Abstract
pdf
|
|
Business Review Editor |
|
| GSK Licenses Phase II Compounds from Exelixis |
Abstract
pdf
|
|
Business Review Editor |
|
| GeneSoft Licenses Rights to Factive from LG Life Sciences |
Abstract
pdf
|
|
Business Review Editor |
|
| Merck KGaA Licenses Niaspan and Advicor from Kos |
Abstract
pdf
|
|
Business Review Editor |
|
| GSK Licenses SGLT2-inhibitor from Kissei |
Abstract
pdf
|
|
Business Review Editor |
|
| Enzon’s Acquisition of Abelcet |
Abstract
|
|
Business Review Editor |
|
| The Erectile Dysfunction market |
Abstract
|
|
Business Review Editor |
|
| Therapy Focus: Alzheimer’s Disease |
Abstract
|
|
Business Review Editor |
|
| King Acquires Meridian Medical Technologies |
Abstract
pdf
|
|
Business Review Editor |
|
| Zonagen to Merge with Lavipharm |
Abstract
pdf
|
|
Business Review Editor |
|
| Ardana Bioscence to Distribute Striant™ Testosterone Product in Europe |
Abstract
pdf
|
|
Business Review Editor |
|
| Schering-Plough to Distribute Novartis Asthma Product in US |
Abstract
pdf
|
|
Business Review Editor |
|
